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Abstract 
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is gaining 
widespread use in the treatment of severe cardiorespiratory failure. Blood volume expansion is 
commonly used to increase ECMO flow (QECMO), with risk of positive fluid balance and 
worsening prognosis. We studied the effects of vasoconstriction on recruitment of blood volume 
as an alternative for increasing QECMO, based on the concepts of venous return. 
Methods: In a closed chest, centrally cannulated porcine preparation (n=9) in ventricular 
fibrillation and VA-ECMO with vented left atrium, mean systemic filling pressure (MSFP) and 
venous return driving pressure (VRdP) were determined in Euvolemia, during Vasoconstriction 
(norepinephrine 0.05, 0.125 and 0.2µg/kg/min) and following Volume Expansion (3 boluses of 
10mL/kg Ringer´s lactate). Maximum achievable QECMO was examined. 
Results: Vasoconstriction and Volume Expansion both increased maximum achievable QECMO, 
delivery of oxygen (DO2) and MSFP, but right atrial pressure increased in parallel. VRdP did not 
change. The vascular elastance curve was shifted to the left by Vasoconstriction, with 
recruitment of stressed volume. It was shifted to the right by Volume Expansion with direct 
expansion of stressed volume. Volume Expansion decreased resistance to venous return and 
pump afterload.  
Conclusions: In a circulation completely dependent on ECMO support, maximum achievable 
flow directly depended on the vascular factors governing venous return - i.e. closing conditions, 
stressed vascular volume and the elastance and resistive properties of the vasculature. Both 
treatments increased maximum achievable ECMO flow at stable DO2, via increases in stressed 
volume by different mechanisms. Vascular resistance and pump afterload decreased with Volume 
Expansion. 
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Introduction: 
Extracorporeal membrane oxygenation (ECMO) has gained widespread use over the last decade 
for the treatment of severe cardiorespiratory failure and cardiac arrest. Despite remarkable 
technical improvements with improved system biocompatibility and centrifugal instead of roller 
pumps, the outcome of cardiogenic shock, extracorporeal resuscitation and post-cardiotomy 
shock remains modest at best (6-8). The physiology of ECMO is incompletely understood and 
data on hemodynamic support to optimize ECMO-flow with volume or vasopressors for patients 
on veno-arterial ECMO are scant (6, 8). Low blood flow and positive fluid balance on ECMO 
are strong predictors of mortality (28, 33). Volume expansion is the common choice for 
increasing ECMO flow (2), despite the risks of progressively positive fluid balance with 
worsening prognosis. 
We and others have shown that the ECMO blood flow is directly dependent on venous return 
(VR) (13, 22), which is described as: 
 
VR = (MSFP – RAP)/RVR     (1) 
The mean systemic filling pressure (MSFP) is the elastic recoil pressure in the systemic 
vasculature (3), caused by the stressed blood volume and the vascular compliance. It can be 
measured in no-flow states (27). Conceptually, venous return driving pressure (VRdP), the 
gradient between MSFP and right atrial pressure (RAP) drives VR against the resistance to 
venous return (RVR) which reflects the lumped resistance of all vascular beds for blood 
returning to the heart (22). As around 70% of blood resides in the venous pool and the majority 
is unstressed, vasoconstriction can increase stressed volume and MSFP via recruitment of 
unstressed volume (19). This has been shown for epinephrine (5, 21), various 1- and 2-
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agonists (1) and norepinephrine (11). An approach to limit volume expansion while achieving 
increased ECMO flow may clinically be beneficial. Since outcome data on optimal supportive 
hemodynamic treatment for VA-ECMO is currently lacking, a study on the underlying 
mechanisms of action for available treatments could provide the basis for clinical decision-
making. 
  
In this porcine model of ventricular fibrillation and veno-arterial (VA) ECMO support, we 
compared the effects of volume expansion with Ringer’s lactate and vasoconstriction using 
norepinephrine on ECMO blood flow and delivery of oxygen (DO2). Based on the concepts of 
venous return and recruitment or expansion of stressed vascular volume (19), we hypothesized 
that both volume expansion and vasoconstriction with norepinephrine could increase maximum 
achievable ECMO flow, although acting on stressed vascular volume via different mechanisms. 
We further hypothesized that the limits of ECMO flow are set by stressed volume and vascular 
circuit properties, rather than performance of the mechanical pump. 
 
Material and Methods: 
 
The study complied with the Guide for the Care and Use of Laboratory Animals (National 
Academy of Sciences, 1996) and Swiss National Guidelines and was approved by the 
Commission of Animal Experimentation of Canton Bern, Switzerland (BE 16/17) Twelve 
domestic pigs (7 female, 5 male, mean body weight 40.0 ± 2.0 kg at twelve weeks of age) were 
fasted for 12 h with free access to water after a three day quarantine under veterinary observation 
at the animal hospital of the University of Bern. The first three animals were used in pilot studies 
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to establish the instrumentation and feasibility of procedures. As previously described (4, 22), 
after premedication with intramuscular ketamine (20 mg/kg) and xylazine (2 mg/kg), vascular 
access was established and anaesthesia was induced with midazolam (0.5 mg/kg) and atropine 
(0.02 mg/kg) followed by intubation and placement of a gastric tube. 
Anaesthesia was maintained with propofol (4 mg/kg/h) and fentanyl (5 μg/kg/h) and the depth 
was controlled by repeatedly testing the response to nose pinch and targeting a bispectral index 
<60 (BIS Quatro, Covidien, Mansfield, MA, USA). During surgery, propofol and fentanyl 
infusions were increased to 6 mg and 20 μg/kg/h respectively. Additional injections of fentanyl 
(50 μg) or midazolam (5 mg) were given as needed. Cefuroxime (1.5 g) was given at skin 
incision and repeated after 4 h. Intermittent muscle relaxation was induced with rocuronium (0.5-
1 mg/kg) for the study measurements. The pigs were mechanically ventilated in a volume-
controlled mode (Servo-I, Maquet Critical Care, Solna, Sweden) using a PEEP of 5 cm H2O, 
fraction of inspired oxygen of 0.30, I:E ratio 1:2 and tidal volume 7 mL/kg body weight. 
Respiratory rate was adjusted to maintain an end-tidal PCO2 of 40 mmHg. 
Installations:  
The following catheters were surgically placed: a left carotid artery catheter, a right jugular 
three-lumen catheter and an introducer sheath in the right femoral vein for rapid volume 
exchange. Cystostomy was performed for urinary output monitoring. The thoracic cavity was 
entered via a median sternotomy and the pericardium was opened. After administration of 5000 
U of heparin, the right atrium (RA), the ascending aorta and left atrium were cannulated (29 Fr 
3-stage venous cannula MC2X, 18 Fr elongated-one-piece arterial cannula and 16 Fr DLP left 
atrial vent, Medtronic, Minnesota, USA) and connected to an ECMO circuit (centrifugal pump, 
non-pulsatile flow, Cardiohelp MECC set, Quadrox oxygenator, Maquet, Rastatt, Germany). The 
Copyright © 2018 by the Shock Society. Unauthorized reproduction of this article is prohibited.
VA-ECMO circuit had a shunt between the arterial and venous tubing. Clamping the inlet and 
outlet tubing while opening the shunt enabled rapid pressure and volume equilibration (22, 27). 
Flows in the pulmonary artery and the ECMO circuit were measured with appropriate transit 
time ultrasonic flow probes (PAU and ME9 PXL Tubing flow sensors respectively, Transonic, 
Ithaca, USA) and were monitored in real time to assist in volume and pump speed management 
(see below). Ventricular epicardial electrodes (MYO/Wire Temporary Atrial Cardiac Pacing 
Wires, A&E Medical Corporation, Farmingdale, New Jersey, USA), and passive pleural drains 
were placed. The pericardium, sternum and wound layers were closed. Intermittent heparin 
boluses were used to keep an activated clotting time > 180 s. During ECMO, tidal ventilation 
was continued with a respiratory rate fixed at 16/min and fraction of inspired oxygen of 0.21. 
The sweep gas flow (100% O2) was adjusted to keep arterial PO2 and PCO2 in the normal range 
(ABL90Flex, Radiometer Medical ApS, Brønshøj, Denmark).  
Pressure measurement and data acquisition: 
Intravascular and airway pressures were measured using transducers (xtrans, Codan Medical, 
Lensahn, Germany) and a multi-modular monitor (S/5 Critical Care Monitor, Datex-Ohmeda, 
GE Healthcare, Helsinki, Finland) which also provided continuous electrocardiography and end-
tidal PCO2. Output from the monitor and flow probes was recorded at 100 Hz in a data 
acquisition system (LabVIEW, National Instruments, Austin, TX, USA), and processed offline 
using customized analysis software (Soleasy, Alea Solutions, Zürich, Switzerland). The tip of the 
catheter used for right atrial pressure measurement, the venous drainage cannula, the inlet port of 
the ECMO pump, and all pressure transducers were fixed to the height of the mid-RA and 
verified by open chest palpation. Pressures were zeroed against the atmosphere and two-point 
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calibrated using a water manometer. Flow probes were zeroed and calibrated electronically. 
Baseline drift for pressure and flows was checked at the end of the experiment. 
Fluid administration, volume state and ECMO pump speed: 
During surgery, Ringer’s lactate was infused at a rate of 10 mL/kg/h and thereafter reduced to 2 
mL/kg/h. Hydroxyethyl starch (HES, 6% Voluven, Fresenius Kabi, Bad Homburg, Germany) 
was supplemented for measured blood loss during surgery (150 ± 109 mL). After closing the 
chest and allowing a stabilization period of 30 min ECMO flow (QECMO) was adjusted to achieve 
a mixed venous O2 saturation (SVO2, measured in the RA) of 50% (lower normal limit for pigs). 
During this period, if necessary, HES was added in 50 mL boluses to allow sufficient QECMO to 
reach the SVO2 target, and to avoid RA collapse during tidal ventilation (total volume of HES, 
including that for blood loss replacement was 197 ± 199 mL). After this stage, defined as 
Euvolemia, no more HES was allowed. 
Experimental protocol: 
Ventricular fibrillation was induced by high rate pacing (1000 bpm, ventricular electrical output 
18 mV, Pace 203, Osypka, Berlin, Germany). The protocol consisted of eight experimental 
conditions: Euvolemia was followed by three conditions of stepwise increasing rates of 
norepinephrine infusion [0.05, 0.125, and 0.2 µg/kg/min, each beginning with a bolus of 5 µg/kg 
(Vasoconstriction 1-3 respectively)], with study measurements starting after five mins at each 
infusion rate. After completing measurements at Vasoconstriction 3, the norepinephrine rate was 
halved and three mins later discontinued completely, entering a state of Post Vasoconstriction. 
This was followed by three conditions of stepwise Volume Expansion (VE1-3) where 10 mL/kg 
of Ringer’s lactate was infused over three mins at each step, with study measurements starting 
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after five mins (Figure 1). After completing the measurements, the animals were killed in deep 
anesthesia by withdrawing the ECMO support. 
ECMO pump speed manoeuvers and venous return curves: 
For each experimental condition, during tidal ventilation, Maintenance ECMO pump speed was 
adjusted to achieve a QECMO resulting in SvO2 of 50%. In order to find the Maximum QECMO 
achievable without provoking clinically apparent RA collapse, the pump speed was increased 
during expiratory hold while observing the real-time flow, displayed on screen, and the ECMO 
tubing for signs of fluttering. The Maintenance and Maximum ECMO pump speeds and 80%, 
60% and 50% thereof were applied during expiratory hold. Manoeuvers lasted for 30 s, after 
which pump speed was reset to Maintenance and tidal ventilation for at least 1 min until blood 
pressure returned to baseline. Data was extracted (as mean) for two seconds 9 s into hold after 
flow had reached its new steady state (4). In order to properly characterize the vascular return 
function, knowing from a previous experiment that unapparent closing conditions may occur 
(22), venous return curves of RAP-QECMO data pairs were constructed after excluding all 
manoeuvers displaying vascular collapse in the offline analysis (independently assessed by 
authors PWM, AH, DB). Maximum achievable QECMO however, was analysed with closing 
conditions included. To quantify the effect of the left atrial vent, in six animals in Euvolemia, 
Vasoconstriction 3, and VE3, manoeuvers with maximum and 50% pump speed were repeated 
with the vent closed. In order to quantify the shift of the venous return curves between 
Vasoconstriction 3 and VE3, QECMO was calculated for standard RAP, representing the mean of 
all conditions. Oxygen delivery (at Maintenance and Maximum QECMO) and oxygen consumption 
(VO2; at Maintenance QECMO) were calculated using standard formulas for arterial and mixed 
venous blood oxygen content. 
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Determination of MSFP 
MSFP was determined after the pump speed manoeuvers in each condition in a Stop flow 
manoeuver (22). The ECMO circuit was clamped with open shunt in expiratory hold (22). Flow 
was resumed after 30 s or if signs of a reflex-mediated increase in arterial blood pressure (ABP) 
were seen. MSFP was taken as the mean value of RAP during two seconds of equilibrium 
defined from ABP nadir (22). At least 3 min were allowed for blood pressure to return to 
baseline. Stability of MSFP was studied at Vasoconstriction 3 and VE3 by repeating the MSFP 
determinations three times over 40 minutes. 
Blood volume determination:  
Plasma volume was measured using indocyanine green dye dilution at Euvolemia, 
Vasoconstriction 3, and VE3, as previously described (4). Changes in plasma volume were 
calculated based on hematocrit and hemoglobin concentrations using Beaumont’s method (16) 
when no direct plasma volume measurements were available.  
Determination of vascular elastance, stressed and unstressed volumes: 
Vascular elastance (Evasc) was determined at Vasoconstriction 3 and VE3 using the difference 
between MSFP obtained before and immediately after rapid bleeding of 9 mL/kg from the 
arterial ECMO tubing into a transfusion bag. The bled volume was re-transfused. Systemic 
vascular elastance was calculated as Evasc = ΔMSFP/ΔBV. Stressed and unstressed volumes were 
determined from the x-intercept of the Evasc function (4, 23).  
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Statistics:  
Based on previous data, a sample size of eight animals was needed to detect a clinically relevant 
difference in MSFP of 1 mmHg (4). Data were analysed using SPSS software (Version 21; SPSS 
Inc., Chicago Illinois, USA). Two-way repeated measurements analysis of variance (ANOVA), 
within-subject factors treatment (vasoconstriction vs. volume expansion) and level of treatment 
intensity (0-3), was used to assess the effects of interventions. In case of significant interaction 
(treatment × intensity), each treatment was tested separately with one-way repeated 
measurements ANOVA to assess where changes occurred. Bonferroni correction was applied as 
appropriate. The vent effect was assessed with two-way repeated measurements ANOVA 
(within-subject factors condition [Euvolemia, Vasoconstriction 3 and VE 3] and pump speed 
[maximum vs. 50%]). Blood volumes, elastances and hemoglobin concentrations 
(Vasoconstriction 3 vs. VE3), and urine output during Vasoconstriction 1-3 vs. VE 1-3 were 
compared with paired t-test. Generalized estimating equations [(GEE) first order auto-regressive 
working correlation matrix] was used to characterize the linear relations between flow vs. pump 
speed, pressure head vs. flow, MSFP vs. time, and the venous return function flow vs. RAP. 
Proportion of variance for these variables in individual animals was assessed as Pearson 
correlation coefficient squared (r2). Assumptions of equal variance and normality were assessed 
as studentized residuals < ±3, visually by Q-Q plots and histograms, and by Kolmogorov-
Smirnov testing. 
Results 
Ventricular fibrillation could be achieved in all nine animals with complete cessation of 
pulmonary artery blood flow (7 ± 12 mL/min over all conditions). Opening or closing the vent 
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did not affect QECMO (range of relative changes, open to closed, 98.4 ± 3.3% to 100.1 ± 0.7% ), 
with no difference seen between conditions or pump speeds (p=0.502 and 0.598 respectively). 
Pump function (mL/revolution) was highly linear over the experimental conditions and pump 
speeds used [r2 (median, range) for individual animals over Euvolemia, Vasoconstriction 3 and 
VE 3 0.999 (0.811 – 1.0), Supplemental Digital Content, Table e1 and Figure e1, 
http://links.lww.com/SHK/A762]. 
Both treatments progressively increased MSFP. For the doses used, the effect was more 
pronounced for Volume Expansion. Mean arterial pressure was higher with Vasoconstriction. 
Hemoconcentration and hemodilution were seen with Vasoconstriction and Volume Expansion 
respectively. The blood lactate increased together with VO2 despite maintenance of the target 
SvO2 (Table 1). Factors defining venous return were not different between Euvolemia and Post 
Vasoconstriction (Supplemental Digital Content, Table e2, http://links.lww.com/SHK/A762). 
Urine output was 2.6 ± 1.1 vs. 2.7 ± 1.4 mL/kg/h during Vasoconstriction 1-3 and Volume 
Expansion 1-3 respectively (n=6, p=0.832). 
 
Maximum ECMO flow 
Both treatments increased maximum achievable QECMO. For the doses used, the effect was more 
pronounced for Volume Expansion, but this did not translate into higher DO2 compared to 
Vasoconstriction, due to concomitant hemodilution (Table 2). 
Venous return function  
Signs of vascular collapse were observed in 17 % of pump speed manoeuvers with equal 
distribution between treatments. When pump speeds were varied, there was a linear negative 
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correlation between QECMO and RAP [median for individual QECMO/RAP responses r2 0.975 
(0.626-1.000); Table 3, Figure 2]. MSFP and flow increased significantly with both treatments, 
and the respective VR curves were shifted to the right (Tables 1-2, Figure 2; for VR plots with 
all data pairs included, see Supplemental Digital Content, Table e3, Figure e2, 
http://links.lww.com/SHK/A762). Increase in flow was less pronounced in Vasoconstriction 
compared to Volume Expansion (Table 2). VRdP was not different between conditions and at 
maintenance speed (Table 1 and 4). The response of resistance to venous return from 
Vasoconstriction was highly variable, with equal distribution of increasing, decreasing or 
unchanged RVR in individual animals (p=.445). Volume Expansion consistently and 
progressively reduced RVR (Tables 3-4, Figure 2). The flow corresponding to the standard RAP 
of 2.8 mmHg was 2978 ± 1046 mL/min in Euvolemia and increased to 3529 ± 648 mL/min 
during Vasoconstriction 3 and to 6195 ± 1787 mL/min during VE3 (p <0.0005, for details see 
Supplemental Digital Content, table e4, http://links.lww.com/SHK/A762). 
Pressure head vs. QECMO 
The relationship between pressure head (mean arterial pressure MAP minus RAP) and QECMO, 
was highly linear in all conditions. (r2 for individual animals (median, range) in Euvolemia: 
0.983 (0.936-0.999); Vasoconstriction 3: 0.990 (0.969-1.000); and VE3: 0.965 (0.643-0.995). 
The resistance needed to be overcome by the pump was lower in VE3 as compared to Euvolemia 
and/or Vasoconstriction 3 (GEE, Table 5). 
Vascular elastance, stressed and unstressed blood volumes 
Compared to Euvolemia, Vasoconstriction increased MSFP and decreased total blood volume 
due to loss of plasma (Table 1 and 6, Figure 3). Volume Expansion restored and increased the 
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blood volume slightly above the base level at Euvolemia due to plasma expansion. 
Vasoconstriction resulted in higher vascular elastance than Volume Expansion. Vasoconstriction 
led to a leftward shift of the elastance curve, and unstressed volume was recruited into stressed 
volume. Volume Expansion shifted the elastance curve back to the right, through increases in 
both stressed and unstressed volumes (Table 6, Figure 3). 
Stability of effects 
At Vasoconstriction 3 and VE3, repeated measurements of MSFP over 40 minutes showed a 
decline over time (mean 1.7 mmHg), with no difference between treatments (GEE, Supplemental 
Digital Content, Table e5, http://links.lww.com/SHK/A762). Changes in plasma volume under 
these conditions were small (0.3 ± 6.5% for Vasoconstriction 3, -2.5 ± 7.7% for VE3, p=0.24). 
Discussion 
We have applied the principles of venous return (13-15), verified in a series of experiments with 
(22), and without mechanical circulatory assist (4, 27, 31), to modern VA-ECMO treatment. We 
found that both vasoconstriction with norepinephrine and volume expansion increased MSFP 
and the maximum achievable QECMO with similar oxygen delivery. The effect of volume 
expansion on blood flow was larger than that of vasoconstriction. In our model, the ECMO pump 
replaces the cardiac function. The pump function was constant, as indicated by the linear 
relationship between pump flow and revolutions per minute (rpm). Accordingly, our results can 
be interpreted solely as changes in the circuit properties, as we have previously demonstrated 
(22). The evaluation of effects and mechanisms of vasoconstriction and volume expansion on 
ECMO flow is highly relevant for the clinical application of modern ECMO treatment. 
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The maximum ECMO flows in each condition were associated with imminent vascular collapse, 
which could not be observed clinically. The vascular collapse, when present, dissociated the 
QECMO-RAP relationship, since RAP no more served as the backpressure for VR (22, 34). 
Closing conditions via vascular waterfalls were recognized as the main limitation to further flow 
increase in the early seminal studies by Guyton (14, 15). The venous return plots showed a 
strictly linear RAP-QECMO relationship (Figure 2), as predicted by Guyton’s model. As we had 
hypothesized, both Vasoconstriction and Volume Expansion allowed for increasing maximum 
ECMO flow and increased MSFP. In this sequential treatment study design, we observed larger 
effects regarding blood flow from volume expansion than from vasoconstriction. Both treatments 
thereby shifted the VR curve to the right. In addition, Volume Expansion also decreased 
resistance to venous return. As compared to Euvolemia, the increase in flow under 
Vasoconstriction was accompanied by decreased total blood volume (a leftward shift of the 
vascular elastance curve) and increased MSFP by recruitment of stressed volume from 
unstressed vascular volume (Figure 3). Recruitment of stressed volume was modified by two 
phenomena. Firstly, vasoconstriction with norepinephrine increased the vascular elastance (29) 
and thereby increased MSFP for the given stressed volume. We did not measure elastance in 
Euvolemia and therefore cannot quantify the elastance increase under Vasoconstriction. The 
value of elastance reported here under norepinephrine is larger than we found in a similar 
experiment under euvolemic conditions (4), and increasing elastances have been shown for 
different vasoconstrictors (1, 11). Secondly, roughly a fifth of the plasma volume and therefore 
part of the recruited volume may have been lost by plasma leakage. Plasma leakage may be 
related to inflammation induced by use of extracorporeal circulation (20). Volume Expansion 
shifted the elastance curve further to the right. Stressed and unstressed volumes were both 
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expanded, but to a lesser extent than expected from the large amount of volume infused (30 
mL/kg). As urinary output remained stable between conditions, this rightward shift may have 
been limited by ongoing plasma leakage and/or increases in vessel bed diameter, as described 
below.  
For both Vasoconstriction and Volume Expansion, the maximum flow increased. Maximum 
flows were often associated with vascular collapse. Under closing conditions, the MSFP-RAP 
pressure gradient does not reflect the driving pressure for venous return. When venous return 
was evaluated in conditions without signs of collapse, a decrease in RVR following volume 
expansion was evident, and explains the further increase in VR despite unchanged VRdP. 
Recruitment of stressed from unstressed volume via vasoconstriction of veins and venules can 
occur without changes in the resistance to venous return (9, 10), which is here reproduced with 
an unchanged slope on average (representing RVR) of the Vasoconstriction VR curves (Tables 
3-4, Figure 2). Notably, individual responses to norepinephrine varied, exhibiting unchanged, 
rising of falling resistances. Such variable reactions of venous return to vasoconstriction have 
been reported earlier (18) and are clinically important, when VA-ECMO is used as support for 
severe heart failure, as increases in resistance and afterload may have detrimental effects (25). 
Maximum flow may have been influenced by cannula tip-vessel wall interaction (34) via 
centralisation of blood volume from vasoconstriction. We have therefore estimated the increases 
in QECMO at a standardized RAP, in order to exclude artefacts from dissociated QECMO and RAP, 
which confirmed the flow increases and curve shifts. Volume Expansion showed progressively 
and uniformly lower RVR and pressure heads, allowing higher flows at stable VRdP. Despite 
higher flow from volume expansion, oxygen delivery was limited due to concomitant 
hemodilution, and the resulting DO2 was similar in the two treatments. Besides resistance 
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changes, an additional mechanism may be at play with volume expansion. The linear pump 
function illustrates that the flow generated per rpm will depend on the variables of the Hagen-
Poiseuille equation (17), i. e. flow is directly proportional to the pressure gradient (or head) and 
the fourth power of vessel radius, but inversely proportional to viscosity and tubing length. The 
pressure heads and RVR at Volume Expansion may have been influenced by viscosity changes 
due to hemodilution or -concentration. Whether the decreasing resistances are a direct 
vasodilatory effect of Volume Expansion after vasopressor weaning, as is clinically often seen 
(30), or if ongoing SIRS and instability of the experimental preparation were the cause of 
vasodilation, cannot be determined with certainty.  
What are the clinical consequences of our findings? Operating close to the maximum possible 
flow brings a high risk of clinically unapparent closing conditions. Volume depletion and high 
airway pressure (4, 32) may increase the likelihood of vessel closure or directly reduce venous 
return via elevated right atrial pressure (22, 27, 31). Preferential drainage from the inferior caval 
vein (which in pigs has an intrathoracic part exposed to pleural pressure) with a three-stage 
cannula may have promoted vessel collapse and dissociated flow from right atrial pressure (34) 
as compared to a right angle cannula in a previous experiment (22). In the absence of clear 
evidence for optimal hemodynamic supportive measures, the clinician’s choice between volume 
expansion and vasoconstriction should be guided by the disease process and the expected 
physiological limits and effects of a treatment.  
Vasoconstriction may allow increase in flow by recruitment of stressed volume and thereby 
decreasing the need to infuse volume, where the amount is associated with worsening outcome 
for patients on VA-ECMO (28). Such volume sparing effects may be of special value in cases of 
severe respiratory failure. The physiological reaction to vasoconstriction is much more variable 
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and therefore less predictable than that of volume expansion. Especially the increases in 
resistance may have negative effects in patients with failing hearts supported with temporary 
mechanical assist. Here, prudent volume expansion to facilitate vasodilation may be appropriate. 
As the components of venous return are not easily measured, monitoring the true effects of 
vasoconstriction is demanding. As a compromise, ECMO blood flow may be kept as low as 
clinically reasonable and adverse effects of repeated vascular collapse need to be considered 
when high flows are necessary. Vasoconstriction and volume expansion, as used in this study, 
are equal regarding oxygen delivery. Both show a similar decline in MSFP over time, probably 
due to ongoing plasma leakage. Plasma leakage under vasoconstriction has been described (12). 
The upper limit for recruitment of unstressed volume into stressed volume using vasoconstriction 
is reported as 10 to 18 mL/kg (19). Up to 3/4 of volume expansion with crystalloids will be lost 
into the interstitial space over time and eventually impair tissue perfusion in case of severe 
oedema. In pilot animals for this study, we used higher doses of norepinephrine, which led to 
more pronounced leakage and unstable preparation with inability to sustain the SvO2 target. The 
recruitable reserve and the ongoing leakage may be further influenced by inflammation 
associated with ECMO (20), and must be taken into clinical consideration. 
Limitations 
Lack of randomization between Volume Expansion and Vasoconstriction is a limitation. We 
chose the sequential use of norepinephrine followed by volume expansion in order to minimize 
shifts in blood volume before norepinephrine. In clinical use of ECMO vasoconstriction and 
volume expansion are often used simultaneously or consecutively, and their effects are modified 
by deterioration of the underlying disease, ongoing plasma leakage and inflammation. 
Alternatively, volume could have been expanded and then removed to facilitate randomization. 
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Transfusion and bleeding was not possible due to lack of pig blood for volume expansion. The 
ECMO system used did not have a volume reservoir or allow for ultrafiltration. Adding a CRRT 
device would have further increased the technical complexity of an already challenging setup. In 
addition, the effects of ultrafiltration on equilibration between interstitial and intravascular space 
and on vasoregulation would have interfered with restoration of baseline intravascular volume 
state after fluid removal. Our sequential approach was a pragmatic compromise. The main 
determinants of venous return did not differ between the two baseline conditions Euvolemia and 
Post Vasoconstriction. This suggests that the conclusion regarding the basic mechanisms of 
vasoconstriction and volume expansion still hold true at least during an early clinical course on 
VA-ECMO. 
We did not encounter clinical instability during this experiment and similar previous experiments 
(4, 22). Urinary output was stable during both Vasoconstriction and Volume Expansion. We 
attribute the rising lactate to an ongoing inflammatory reaction - a known phenomenon on 
ECMO (20). This is supported by the increasing oxygen consumption in the course of the 
experiment. We cannot exclude gut ischemia or liver dysfunction due to venous outflow 
obstruction but consider them unlikely due to the clinical stability. The continuously fibrillating 
heart may also have contributed, but not to a quantitatively relevant extent. 
We tested whether vasoconstriction and volume expansion could increase maximum achievable 
ECMO flow and assed the underlying mechanisms. Our study was not designed to evaluate a 
treatment benefit of one approach over the other. We show that both volume expansion and 
vasoconstriction, when used in moderate doses, increase maximum achievable ECMO flow, with 
similar effects on DO2. We conclude that ECMO flow is primarily dependent on the factors 
governing venous return - in our view a central finding for anyone in clinical care of ECMO 
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patients. In order to find an optimal treatment regarding outcome, the basic mechanisms should 
be understood. To what degree our findings can be translated to diseases other than cardiac 
arrest, like septic shock or severe pulmonary failure, is still to be explored. Particularly, our 
results cannot be extrapolated to treatment of respiratory failure using veno-venous ECMO. 
We omitted an elastance measurement at Euvolemia, which could have provided interesting 
information as we found changing elastances between Vasoconstriction and Volume Expansion. 
As there is little doubt about the linear behaviour of the elastance curve in the physiological 
range (4, 22) (1, 10, 23), a one-step change of blood volume seems warranted. Values presented 
here are in agreement with previous experiments performed by us and others (4, 24) and 
increasing elastance with vasoconstrictors is well described (1, 11). 
We used low doses of norepinephrine as titration of higher doses in the pilot series led to 
progressive instability. Still, higher doses may have shown clearer results. Similar results to ours 
were found with much higher doses in endotoxemic pig models (9). 
Statistical approach 
Linear regression has been the standard method of describing venous return (27). We could 
reproduce our earlier findings using standardized RAP and Generalized Estimating Equations 
(22), which allowed statistical interference from repeated measurements. 
Validity of RAP and VRdP 
Increasing pump speed shifts volume away from the RA, progressively lowering RAP and 
increasing VRdP (22) – which is the difference of intravascular pressures over a vascular 
segment. The limit of maximum flow however, is determined by transmural pressure (26, 34): at 
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closing conditions, the vascular wall interacts with the cannula tip causing flow to drop with 
subsequent build-up of pressure until wall and cannula separate anew and flow is restored 
(staccato flow) (34). This phenomenon is associated with a net increase in resistance. A RAP 
valid for calculation of VRdP can only be measured at the orifice of unobstructed flow in a 
multistage cannula (14, 34). We therefore verified our main results by estimation of increasing 
flows at standard RAP, independently of VRdP. 
Independently of these limitations, the corollary of our experiment is that in a circulation 
completely dependent on a mechanical pump, maximum pump output is determined by vascular 
factors. This should be taken into consideration in the clinical management. 
Conclusions 
In a circulation completely dependent on ECMO support, blood flow is directly dependent on the 
vascular factors that govern venous return - i.e. closing conditions, stressed vascular volume and 
the elastance and resistive properties of the vasculature. 
Abbreviations 
ABP  arterial blood pressure 
ANOVA analysis of variance 
DO2  delivery of oxygen 
ECMO  extracorporeal membrane oxygenation 
GEE  general estimating equation 
HES  hydroxyethyl starch 
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MAP  mean arterial pressure 
MSFP  mean systemic filling pressure 
PEEP  positive end-expiratory pressure 
RAP  right atrial pressure 
rpm  revolutions per minute 
SVO2  mixed venous oxygen saturation 
VE  volume expansion 
VO2  oxygen consumption 
VR  venous return 
VRdP  Venous return driving pressure (=MSFP – RAP) 
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